Does CBT-I improve anxiety and depression compared with sleeping medication?

Why treating insomnia changes anxiety and depression

Insomnia and mood problems are tightly linked: people with chronic insomnia often have anxiety or depression at the same time, and poor sleep can worsen both. CBT-I targets the thoughts and behaviors that keep insomnia going—things like worrying about sleep, spending too long in bed awake, and irregular sleep schedules—rather than using medication to sedate. By fixing the sleep problem at its behavioral roots, CBT-I may indirectly relieve mood symptoms that were being fueled by poor sleep.

A meta-analysis of 22 randomized trials found that digital CBT-I produced small-to-moderate improvements in depression and anxiety, alongside a large improvement in sleep itself [4]. The mood benefits were smaller than the sleep benefits, which fits the idea that mood gains partly ride on sleep gains. The same analysis found that people who adhered well to the program got stronger mood benefits than those who did not, suggesting the effect depends on actually doing the therapy [4].

How CBT-I stacks up against sleeping medication

The clearest comparison comes from a large retrospective study of over 4,000 patients treated with digital CBT-I, medication, or both. At six months, both CBT-I and combination therapy reduced insomnia severity significantly more than medication alone, and the mood outcomes—anxiety, depression, and somatic symptoms—also showed statistically significant benefits favoring CBT-I and combination therapy over medication [2]. Combination therapy was judged optimal, but CBT-I alone was more effective than medication alone, and this held across different subgroups of patients [2].

One caveat from that study: CBT-I's benefits improved steadily for the first three months and then fluctuated, which the authors described as unstable durability, whereas the comparison with medication was still favorable overall [2]. So the advantage over medication is real in this dataset, but the long-term steadiness of CBT-I's effect was not perfect.

Who tends to benefit most, and what the evidence covers

In a single-arm study of a prescription digital CBT-I program, anxiety and depression scores dropped significantly from baseline to end of treatment and were largely maintained at six months [1]. The largest improvements showed up in people who started with more severe mood symptoms: those with severe anxiety had very large effect sizes, and those with moderate-to-severe depression also improved substantially [1]. That pattern suggests CBT-I may be especially valuable for insomnia patients whose anxiety or depression is already pronounced.

For children and adolescents, the picture is much less settled. A systematic review of seven randomized trials found most studies showed a strong effect of CBT-I on depression, and a positive effect on anxiety was noted, but only a small number of studies looked at anxiety—so the authors called these findings preliminary and urged larger studies [3]. Separately, a study of older adults with insomnia found that CBT-I roughly halved the risk of developing major depression over three years compared with sleep education, though that comparison was against education, not medication [5].

Sources used in this answer

Related research questions